Immune reconstitution and "unmasking" of tuberculosis during antiretroviral therapy.

Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Anzio Road, Observatory 7925, Cape Town, South Africa.
American Journal of Respiratory and Critical Care Medicine (Impact Factor: 11.99). 05/2008; 177(7):680-5. DOI: 10.1164/rccm.200709-1311PP
Source: PubMed

ABSTRACT Tuberculosis (TB) is the most common opportunistic disease in HIV-infected patients during the initial months of antiretroviral therapy (ART) and presents a great challenge to ART programs in resource-limited settings. The mechanisms underlying development of TB in this period are complex. Some cases may represent progression of undiagnosed subclinical disease present before starting ART, emphasizing the importance of careful screening strategies for TB. It has been suggested that progression in such cases is due to immune reconstitution disease-a phenomenon in which dysregulated restoration of pathogen-specific immune responses triggers the presentation of subclinical disease. However, whereas some cases have exaggerated or overtly inflammatory manifestations consistent with existing case definitions for IRD, many others do not. Moreover, since ART-induced immune recovery is a time-dependent process, active TB may develop as a consequence of persisting immunodeficiency. All these mechanisms are likely to be important, representing a spectrum of complex interactions between mycobacterial burden and changing host immune response. We propose that the potential range of effects of ART includes (1) shortening of the time for subclinical TB to become symptomatic (a phenomenon often referred to as "unmasking"), (2) increased rapidity of initial onset of TB symptoms, and (3) heightened intensity of clinical manifestations. We suggest that the term "ART-associated TB" be used to refer collectively to all cases of TB presenting during ART and that "immune reconstitution disease" be used to refer to the subset of ART-associated TB cases in which the effect on disease severity results in exaggerated and overtly inflammatory disease.


Available from: Marc Lipman, Jun 06, 2015
1 Follower
  • [Show abstract] [Hide abstract]
    ABSTRACT: In the past decades, tumor necrosis factor alpha (TNF-a) antagonist has been a milestone in the treatment of many chronic inflammatory diseases. TNF antagonist can increase patients' susceptibility to many different kinds of infections especially those requiring granuloma formations despite regular performance of Screening for latent tuberculosis infection (LTBI). We report 2 cases of patients who developed tuberculosis under treatment with adalimumab, which was discontinued after the diagnosis of tuberculosis. During the tuberculosis therapy they unexpectedly developed a prolonged paradoxical reaction. In both cases we were only able to manage the progress of the paradoxical reaction through high steroid doses. Patients undergoing therapy with TNF-alpha-blocker are prone to develop tuberculosis infection, which could in turn lead to severe prolonged paradoxical reaction during anti-tuberculous treatment. An increased steroid dose may be required and is sometimes necessary.
    01/2015; 10(1). DOI:10.1515/med-2015-0009
  • [Show abstract] [Hide abstract]
    ABSTRACT: Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis, induces formation of granulomas, structures in which immune cells and bacteria co-localize. Macrophages are one of the most abundant cell types in granulomas and have been shown to serve as both critical bactericidal cells and targets for Mtb infection and proliferation throughout the entire course of infection. Very little is known about how these processes are regulated, what controls macrophage microenvironment-specific polarization and plasticity, or why some granulomas control bacteria and others permit bacterial dissemination. We take a computational biology approach to investigate mechanisms that drive macrophage polarization, function, and bacterial control in granulomas. We define a macrophage polarization ratio as a metric to understand how cytokine signaling translates into polarization of single macrophages in a granuloma, which in turn modulates cellular functions including anti-microbial activity and cytokine production. Ultimately, we extend this macrophage ratio to the tissue scale and define a granuloma polarization ratio describing mean polarization measures for entire granulomas. Here we coupled experimental data from non human primate TB granulomas to our computational model and we predict two novel and testable hypotheses regarding macrophage profiles in TB outcomes. First, temporal dynamics of granuloma polarization ratios are predictive of granuloma outcome. Second, stable necrotic granulomas with low CFU and limited inflammation are characterized by short NFκB signal activation intervals. These results suggest that the dynamics of NFκB signaling is a viable therapeutic target to promote M1 polarization early during infection and improve outcome.
    Infection and Immunity 11/2014; 83(1). DOI:10.1128/IAI.02494-14 · 4.16 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective To assess mortality risk among adults presenting to an African teaching hospital with sepsis and severe sepsis in a setting of high HIV prevalence and widespread ART uptake. Methods Prospective cohort study of adults (age ≥16 years) admitted with clinical suspicion of severe infection between November 2008 and January 2009 to Queen Elizabeth Central Hospital, a 1250-bed government-funded hospital in Blantyre, Malawi. Demographic, clinical and laboratory information, including blood and cerebrospinal fluid cultures were obtained on admission. Results Data from 213 patients (181 with sepsis and 32 with severe sepsis; M:F = 2:3) were analysed. 161 (75.6%) patients were HIV-positive. Overall mortality was 22%, rising to 50% amongst patients with severe sepsis. The mortality of all sepsis patients commenced on antiretroviral therapy (ART) within 90 days was 11/28(39.3%) compared with 7/42 (16.7%) among all sepsis patients on ART for greater than 90 days (p=0.050). Independent associations with death were hypoxia (OR=2.4; 95% CI, 1.1-5.1) and systolic hypotension (OR 7.0; 95% CI: 2.4-20.4). Conclusions Sepsis and severe sepsis carry high mortality among hospitalised adults in Malawi. Measures to reduce this, including early identification and targeted intervention in high-risk patients, especially HIV-positive individuals recently commenced on ART, are urgently required.
    Journal of Infection 07/2014; 70(1). DOI:10.1016/j.jinf.2014.07.004 · 4.02 Impact Factor